Abstract
Several 4H-pyrano[3,2-h]quinolone (3, 5, 7, 8, 10, 11, 14, 15, 16 and 17) and 7H-pyrimido[4',5':- 6,5]pyrano[3,2-h]quinoline derivatives (9, 12, 13, 18) were prepared. These compounds were tested in vitro for their antimicrobial activity to show congruent results against the most tested microorganisms as compared with the standards Ampicillin, Streptomycin, Mycostatine and Clotrimazole. The structure activity relationship (SAR) studies of 3 and its analog compounds revealed higher potent antimicrobial activity against the most tested microorganisms. These data indicated that the activity of compounds was considerably attributed to the presence of the electrondonating groups in combination with the electron-withdrawing groups in 4H-pyrano[3,2-h]quinoline moiety. Incorporating a pyrimidine nucleus with pyranoquinoline moiety resulted in changing the potency for some compound. The structures of these compounds were established on the basis of spectral data.
Keywords: 8-Hydroxyquinoline, 8-Hydroxy-2-methylquinoline, (E) 2-(4-Chloro/bromo/-fluorostyryl)-8-hydroxyquinoline, Antimicrobial, SAR.
Letters in Drug Design & Discovery
Title:Evaluation of the Antimicrobial Activity of Some 4H-Pyrano[3,2-h]- quinoline,7H-Pyrimido[4',5':6,5]pyrano[3,2-h]quinoline Derivatives
Volume: 10 Issue: 8
Author(s): Hany M. Mohamed, Ibrahim A. Radini, Abdullah M. Al-Ghamdi and Ahmed M. El-Agrody
Affiliation:
Keywords: 8-Hydroxyquinoline, 8-Hydroxy-2-methylquinoline, (E) 2-(4-Chloro/bromo/-fluorostyryl)-8-hydroxyquinoline, Antimicrobial, SAR.
Abstract: Several 4H-pyrano[3,2-h]quinolone (3, 5, 7, 8, 10, 11, 14, 15, 16 and 17) and 7H-pyrimido[4',5':- 6,5]pyrano[3,2-h]quinoline derivatives (9, 12, 13, 18) were prepared. These compounds were tested in vitro for their antimicrobial activity to show congruent results against the most tested microorganisms as compared with the standards Ampicillin, Streptomycin, Mycostatine and Clotrimazole. The structure activity relationship (SAR) studies of 3 and its analog compounds revealed higher potent antimicrobial activity against the most tested microorganisms. These data indicated that the activity of compounds was considerably attributed to the presence of the electrondonating groups in combination with the electron-withdrawing groups in 4H-pyrano[3,2-h]quinoline moiety. Incorporating a pyrimidine nucleus with pyranoquinoline moiety resulted in changing the potency for some compound. The structures of these compounds were established on the basis of spectral data.
Export Options
About this article
Cite this article as:
Mohamed M. Hany, Radini A. Ibrahim, Al-Ghamdi M. Abdullah and El-Agrody M. Ahmed, Evaluation of the Antimicrobial Activity of Some 4H-Pyrano[3,2-h]- quinoline,7H-Pyrimido[4',5':6,5]pyrano[3,2-h]quinoline Derivatives, Letters in Drug Design & Discovery 2013; 10 (8) . https://dx.doi.org/10.2174/15701808113109990002
DOI https://dx.doi.org/10.2174/15701808113109990002 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design, Synthesis and In-Vitro Cytotoxicity of Novel Platinum (II) Complexes with Phthalate as the Leaving Group
Letters in Drug Design & Discovery Antibacterial Agents Against Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE)
Anti-Infective Agents in Medicinal Chemistry Radioimmunotherapy of Infection with 213Bi-Labeled Antibodies
Current Radiopharmaceuticals Bioactivity of New μ and δ Opioid Peptides
Medicinal Chemistry Kinetics and Mechanism of Oxidation of Paracetamol by Thallic Perchlorate in Acid Medium
Current Physical Chemistry Liver-Based In Vitro Technologies for Drug Biotransformation Studies - A Review
Current Drug Metabolism Therapeutic Exploitation of Endogenous Anti-Inflammatory Mechanisms:Old and New Leads
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Prostate Cancer Prevention in the Developing World - What are we Waiting for?
Current Pharmacogenomics and Personalized Medicine Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry <i>Ralstonia Mannitolilytica</i>, an Unusual Pathogen in the Neonatal Intensive Care Unit: A Case of Neonatal Sepsis and Literature Review
Infectious Disorders - Drug Targets Association Constants of Pyridine and Piperidine Alkaloids to Amyloid ß Peptide Determined by Electrochemical Impedance Spectroscopy
Current Alzheimer Research Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
Clinical Cancer Drugs Pharmacogenetics of Irinotecan
Current Medicinal Chemistry - Anti-Cancer Agents Oyster Mushroom Laccase Inhibits Hepatitis C Virus Entry into Peripheral Blood Cells and Hepatoma Cells
Protein & Peptide Letters Synthesis, Molecular Docking and Anticancer Evaluation of New Arylazothiazoles
Current Organic Synthesis Nanoparticle-Based Diagnosis and Therapy
Current Drug Targets Microwave-Assisted Synthesis and Evaluation of Substituted Aryl Propyl Acridone-4-Carboxamides as Potential Chemosensitizing Agents for Cancer
Letters in Drug Design & Discovery A Proteomics Study of the Subacute Toxicity of Rat Brain after Long- Term Exposure of <i>Gelsemium elegans</i>
Current Molecular Pharmacology The Impetus of COVID -19 in Multiple Organ Affliction Apart from Respiratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy
Infectious Disorders - Drug Targets Chromogranin A as a Calcium-Binding Precursor for a Multitude of Regulatory Peptides for the Immune, Endocrine and Metabolic Systems
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents